As an example, consistent with studies in cancer cells, we found that Nrf2 significantly boosted several genes in the pentose phosphate pathway, including those for glucose-6-phosphate dehydrogenase (G6pd), transaldolase 1 (Taldo1), and phosphogluconate dehydrogenase (Pgd) (60). The gene discussed is PGD; the disease is cancer.